New European Guidelines on Pulmonary Embolism: What Has Changed and …

PERT Consortium 2021

S. Konstantinides

TCT 2022: Why Intervene on Submassive Pulmonary Embolism Patients?

TCT 2022 Conference Coverage

W. Jaber

Lessons Learned From Trials of Implementation: The CLABSI Section of…

AVA at Your Fingertips

V. Chopra

What Is Truly Informed Consent and Should The Perfusionist Get His/H…

The New Orleans Conference

Catheter-Based Interventions for Acute Pulmonary Embolism: What Are …

Mount Sinai Endovascular Fellows Course

J. Giri

Update on HI-PEITHO - A Landmark Clinical Trial in PE

PERT Consortium 2022

K. Rosenfield

Pulmonary Embolism: Where Are We in 2024?

UPMC

B. Rivera-Lebron

Catheter-Directed Thrombolysis Is the Preferred Approach for the Tre…

PERT Consortium 2022

P. Monteleone

Understanding the changing landscape of cardiovascular economics

Innovations in Cardiovascular Therapeutics 2016

Strategies to Reduce Low Value Care

American Society of Echocardiography

G. Rose

Panel Discussion: Acute vs Chronic Changes in PE, Anticoagulation Du…

The North American Thrombosis Forum (NATF)

G. Piazza, J. Rodriguez-Lopez, B. Bikdeli, A. Witkin, F. Rahaghi, A. Wong

Interventions for PE in 2021: Papers You Need to Know

PERT Consortium 2021

J. Moriarty

CHEST 2024 Insights: Optimal Approach for Intermediate-High Risk PE

CHEST Annual Meeting Insights

H. Freeman

Shock with Pulmonary Embolism

Scripps Health

C. Stinis

What's New in Interventional Pulmonary Embolism Therapy?

ARCH Advanced Revascularization Symposium

T. Tu

Regulatory Pathways for PE Management: Panel Discussion

PERT Consortium 2021

K. Rosenfield, B. Keeling, S. Lossef, T. Bowers, E. Secemsky